SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 24.63 |
| Enterprise Value ($M) | 24.63 |
| Book Value ($M) | 0.00 |
| Book Value / Share | 0.00 |
| Price / Book | n/a |
| NCAV ($M) | 0.00 |
| NCAV / Share | 0.00 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | n/a |
| Current Ratio | n/a |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 0.00 |
| Assets | 0.00 |
| Liabilities | 0.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 46.47 |
| Operating Income | -2.61 |
| Net Income | -7.78 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.31 |
| Cash from Investing | -4.74 |
| Cash from Financing | -2.92 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 4,834 | 16,001 | 30.21 | |
| 5,337 | 23,446 | 22.76 | |
| 1,374 | 8,396 | 16.36 | |
| 21,689 | 51,692 | 41.96 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PTPI – Petros Pharmaceuticals, Inc. | PULM – Pulmatrix, Inc. |
| QLGN – Qualigen Therapeutics, Inc. | RENB – Renovaro Inc. |
| REVB – Revelation Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io